CClinicalTrials.gg
Active, not recruitingNCT03408717B-CAPPUpdated Aug 7, 2026

Evaluation And Risk Assessment For Persistent Postsurgical Pain After Breast Surgery

An observational study in Breast Cancer, Chronic Pain and Acute Pain, sponsored by KK Women's and Children's Hospital. Active, not recruiting at 2 sites in 2 countries. Open to female participants aged 21 Years to 80 Years. Per ClinicalTrials.gov, last updated 2026-08-07.

Sponsored by KK Women's and Children's Hospital · Observational

Study type
Observational
Model
Other
Time perspective
Prospective
Enrollment
220
Ages
21 Years to 80 Years
Sex
Female
01

Study summary

Pre-existing pain and severe postoperative pain are predictors of persistent pain after surgery, but a complete understanding on the development of persistent pain is still lacking. The study aims to identify clinically relevant and genetic risk factors for persistent postsurgical pain that can be reliably distinguished statistically.

Read the detailed description

The study will focus on: (i) risk factors representing biopsychosocial processes that influence chronic pain, such as pain and psychological vulnerability; (ii) genetic factors relating to mechanistic pathways to persistent pain generation. Patients will be recruited from those undergoing breast cancer surgery at the mentioned site. Pain and anxiety assessment will be conducted via visual analogue scoring, mechanical temporal summation assessment and a series of questionnaires. After the surgery, all patients will be given appropriate analgesia, and the pain score and analgesia usage will be recorded. Phone survey will be conducted 4 and 6 months, respectively, after surgery to determine the outcomes.

02

Conditions studied

  • Breast Cancer
  • Chronic Pain
  • Acute Pain
  • Depression, Anxiety

Keywords

  • Breast cancer
  • Chronic pain
  • Acute Pain
  • Depression
  • Anxiety
03

Who can participate

Ages eligible
21 Years to 80 Years
Sexes eligible
Female
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

Patients undergoing breast cancer surgery

Inclusion criteria

  • Aged between 21 - 80 year old;
  • Healthy and/or have systemic medical conditions as reviewed by anaesthetist for surgery (ASA 1-3);
  • Undergoing breast cancer surgery.

Exclusion criteria

Exclusion Criteria:

  • History of intravenous drug or opioid abuse;
  • Current chronic daily treatment with corticosteroids (excluding inhaled steroids);
  • Previous history of chronic pain syndrome;
  • Obstetric patients.
04

Study design

Observational model
Other
Time perspective
Prospective
Enrollment
220 participants (estimated)
Patient registry
No
Biospecimen retention
Samples with dna

Groups and cohorts

  • Persistent post surgical pain (PPSP)

    Questionnaires, Mechanical Temporal Summation assessment and pain threshold assessment will be assigned to patient. Within this cohort, some patients will have high pain score recorded (persistent pain) during the follow-up evaluations at 4 and 6 months.

    Other: Questionnaires · Other: Mechanical Temporal Summation assessment · Other: Pain threshold assessment

Interventions

  • OtherQuestionnaires

    Questionnaires including Pain catastrophizing scale (PCS), Central Sensitisation Inventory (CSI), Coping Strategies Questionnaire-Revised (CSQ-R), Brief Symptom Inventory-18 (BSI-18), Perceived Stress Scale (PSS), EQ-5D-3L and Eysenck Personality Questionnaire (EPQ) will be administered to the patient.

  • OtherMechanical Temporal Summation assessment

    A 180 gram von Frey filament is applied on the subject's forearm. Patient will then be asked to rate the pinprick pain score on a verbal rating scale, 0-100. Following this, 10 consecutive touches at random locations are applied with a 1 second interstimulus interval and within a 1 cm diameter circle. The patient will then be asked to rate the 10th pain score (0-100). The Mechanical Temporal Summation Score is obtained by the difference between the 11th pain score and the 1st pain score. If the score is greater than zero, the patient is implied to have presence of Mechanical Temporal Summation.

    Also known as: MTS

  • OtherPain threshold assessment

    Pressure is applied 90 degree straight down force on the subject's right/left centre of the trapezius muscle using an algometer, with a speed of pressure \~ 1kgf/s. The above procedure is then repeated 3 times at each site (left/right) which is indicated on the pressure mark with each time having the reading recorded. When patient shows no response ≥ 6kgf, the threshold is recorded as 6kgf. The patient upon feeling pain will say stop or raise the hand to terminate the test. The mean value is obtained by averaging the readings and will then be recorded as the threshold estimate.

    Also known as: Pressure pain

05

What researchers measure

Primary outcomes

  1. Persistent pain at 4 months after surgery

    Persistent pain is defined as having one of the below criteria at 4 months after surgery: i) having pain score at rest (Numeric Rating Scale 0 to 100) of 30 or more; or ii) having pain score on movement (Numeric Rating Scale 0 to 100) of 30 or more; or iii) or "yes" to one of the seven questions on the presence of pain in daily life activities (mood, walking, carrying heavy loads, work, relations with people, sleep, enjoyment of life)

    Time frame: 4 months after surgery

Secondary outcomes

  1. Persistent pain at 6 months after surgery

    Persistent pain is defined as having one of the below criteria at 4 months after surgery: i) having pain score at rest (Numeric Rating Scale 0 to 100) of 30 or more; or ii) having pain score on movement (Numeric Rating Scale 0 to 100) of 30 or more; or iii) or "yes" to one of the seven questions on the presence of pain in daily life activities (mood, walking, carrying heavy loads, work, relations with people, sleep, enjoyment of life)

    Time frame: 6 months after surgery

  2. Maximum Acute post-operative pain score

    The maximum number of patient-reported post-operative pain score (Numeric Rating Scale 0 to 100) at 0 - 72 hours

    Time frame: Up to 3 days after surgery

  3. Opioid consumption

    The total opioid consumption (morphine/ fentanyl/ hydromorphone/ oxycodone/ hydrocodone etc) throughout the 72 hours. The opioid consumption will be converted using oral morphine equivalent (OME) conversion calculations.

    Time frame: Up to 3 days after surgery

06

Study locations

2 sites
  • Duke University Medical Center
    Durham, North Carolina 27710, United States
  • KK Women's and Children's Hospital
    Singapore, 229899, Singapore
07

References and documents

Study documents

  • Protocol and statistical analysis plan · Jan 18, 2020

Documents are hosted by the registry — open the source record to download them.

Individual participant data

Plan to share: No

08

Registry details

Key details

Study ID
NCT03408717
Lead sponsor
KK Women's and Children's Hospital
Collaborators
Duke University
Responsible party
Sng Ban Leong (Principal Investigator, KK Women's and Children's Hospital) — Principal investigator
First posted
Jan 24, 2018
Start date
Jan 3, 2018
Primary completion
Dec 31, 2026 (estimated)
Completion
Dec 31, 2027 (estimated)
Last update
Aug 7, 2026

Study contacts

Ban Leong Sng, FANZCA
principal investigator · KK Women's and Children's Hospital
Ashraf Habib, MBBCh, FRCA
principal investigator · Duke University

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is active, not recruiting, as verified in Aug 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion